Corrections
ACOG Practice Bulletin No. 194: Polycystic byline is, “Joshua Monson, DO, Womack Army
tex25dJvVw73CUfHYEu2YBGYeRO2GhrARbFheTL5VRrRvQSMC9mvaSayTe2UL9g3RQBAv2cUz7Atjdo5bzzxqClEUOPSU7WHJ32a
Ovary Syndrome: Correction
In “Practice Bulletin No. 194: Polycystic Ovary Syn-
Downloaded from http://journals.lww.com/greenjournal by XQ1fMo+NCTlDzDq+boR3UJNHeW6VN+pxA8qpuxv3HAoL
drome” from the American College of Obstetricians
and Gynecologists,1 there is an error on page e165,
second column, below the heading “Flutamide.” In
the first full sentence, the term “agonist” is incorrect
and should read “antagonist.” The full, corrected
sentence is as follows: “Flutamide, an androgen-
receptor antagonist, is another nonsteroidal antian-
drogen that has been shown to be effective against
hirsutism in smaller trials.”
+70IQLZpPtkJS9Dh on 05/22/2024
REFERENCE
1. Polycystic ovary syndrome. ACOG Practice Bulletin No. 194.
American College of Obstetricians and Gynecologists. Obstet
Gynecol 2018;131:e157–71.
DOI: 10.1097/AOG.0000000000004069
Ovarian Cancer After Prophylactic
Salpingectomy in a Patient With Germline
BRCA1 Mutation: Correction
Debra M. Sarasohn was omitted from the author
byline in the article by Lugo Santiago et al1 in the
June 2020 issue. The correct byline is: “Nicole
Lugo Santiago, MD, Evan Smith, MD, Debra
M. Sarasohn, MD, Mary Cox, BS, Carrie S.
Wan, BSN, RN OCN, Nana E. Tchabo, MD,
Ibraheem Awowole, MD, Vance Broach, MD,
and Dennis S. Chi, MD.”
REFERENCE
1. Lugo Santiago N, Smith E, Cox M, Wan CS, Tchabo NE, Awowole I,
et al. Ovarian cancer after prophylactic salpingectomy in a patient
with germline BRCA1 mutation. Obstet Gynecol 2020;135:1270–4.
DOI: 10.1097/AOG.0000000000004064
Evaluation of a Novel Course in Pre-hospital
Emergency Obstetrics for US Army Special
Forces Medics [11G]: Correction
The byline is incorrect in an abstract in the May
2020 supplement to the journal.1 The correct
638 VOL. 136, NO. 3, SEPTEMBER 2020
© 2020 by the American College of Obstetricians
and Gynecologists. Published by Wolters Kluwer Health, Inc.
Unauthorized reproduction of this article is prohibited.
Medical Center, Ft. Bragg, NC, Katherine Joseph,
DO, Alexandra Carney, DO, and Karen L. Wil-
son, MD.”
REFERENCE
1. Wilson KL, Joseph K, Carney A. Evaluation of a novel course in
pre-hospital emergency obstetrics for US army special forces
medics [11G]. Obstet Gynecol 2020;135:73S.
DOI: 10.1097/AOG.0000000000004089
Effectiveness of Maternal Safety Bundle for
Obstetric Hemorrhage at a Large U.S. Military
Hospital [15M]: Correction
The byline is incorrect in an abstract in the May
2020 supplement to the journal.1 The correct
byline is, “Joshua Monson, DO, Womack Army
Medical Center, Ft. Bragg, NC, Katherine Joseph,
DO, and Karen L. Wilson, MD.”
REFERENCE
1. Joseph K, Wilson KL. Effectiveness of maternal safety bundle for
obstetric hemorrhage at a large U.S. military hospital [15M]. Ob-
stet Gynecol 2020;135:138S.
DOI: 10.1097/AOG.0000000000004090
Improving Access for Patients Undergoing
Gonadotoxic Therapy: Creation of a Formal
Fertility Preservation Program [25A]:
Correction
An author’s name is incorrect in an abstract in the
May 2020 supplement to the journal.1 “Ljeoma
Iko, MD,” is incorrect. The correct name is, “Ijeo-
ma Iko, MD.”
REFERENCE
1. Willson B, Iko L, Cookingham L. Improving access for patients
undergoing gonadotoxic therapy: creation of a formal fertility
preservation program [25A]. Obstet Gynecol 2020;135:14–5S.
DOI: 10.1097/AOG.0000000000004091
OBSTETRICS & GYNECOLOGY